Labiotech – FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field

[image_with_animation image_url=”9174″ animation=”Fade In” hover_animation=”none” alignment=”center” img_link_target=”_blank” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.labiotech.eu/trends-news/fda-approval-of-first-fecal-microbiota-product-rebyota-hailed-fantastic/”]Hervé Affagard, CEO and co-founder of MaaT Pharma, commented on the first FDA-approval for a microbiome therapy.